Akers Biosciences Announces Q3 2018 Earnings
November 15, 2018 07:00 ET
|
Akers Biosciences Inc.
Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROFARE, N.J., Nov. 15, 2018 ...